Lombard Odier Asset Management (Switzerland) Sa Biogen Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$212.02 - $267.71 $762,211 - $962,417	3,595 New	3,595 $775,000
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $31,556 - $35,957	123 Added 4.8%	2,686 $746,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $250,168 - $303,959	991 Added 63.04%	2,563 $709,000
Q3 2022 Nov 14, 2022	SELL	$194.69 - $268.46 $481,857 - $664,438	-2,475 Reduced 61.16%	1,572 $420,000
Q2 2022 Aug 15, 2022	BUY	$187.54 - $223.02 $758,974 - $902,561	4,047 New	4,047 $825,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $19.9 Million - $25 Million	-102,484 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $4.06 Million - $5.22 Million	18,138 Added 21.5%	102,484 $24.6 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $2.04 Million - $2.66 Million	7,217 Added 9.36%	84,346 $23.8 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $19.5 Million - $31.3 Million	75,362 Added 4264.97%	77,129 $26.7 Million
Q1 2021 May 17, 2021	BUY	$242.95 - $284.63 $429,292 - $502,941	1,767 New	1,767 $494,000
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $1.7 Million - $2.55 Million	-7,175 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $1.9 Million - $2.19 Million	7,175 New	7,175 $2.04 Million
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $739,250 - $979,007	-2,858 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$268.85 - $341.04 $440,914 - $559,305	1,640 Added 134.65%	2,858 $904,000
Q4 2019 Feb 14, 2020	SELL	$220.06 - $304.07 $109,149 - $150,818	-496 Reduced 28.94%	1,218 $361,000
Q3 2019 Nov 14, 2019	SELL	$217.44 - $243.88 $575,128 - $645,062	-2,645 Reduced 60.68%	1,714 $399,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $650,852 - $717,424	-2,968 Reduced 40.51%	4,359 $1.02 Million
Q1 2019 May 15, 2019	BUY	$216.71 - $338.96 $793,808 - $1.24 Million	3,663 Added 99.97%	7,327 $1.73 Million
Q4 2018 Feb 14, 2019	SELL	$278.5 - $352.75 $1.09 Million - $1.38 Million	-3,914 Reduced 51.65%	3,664 $1.1 Million
Q3 2018 Nov 14, 2018	SELL	$293.51 - $383.83 $4.3 Million - $5.62 Million	-14,641 Reduced 65.89%	7,578 $2.68 Million
Q2 2018 Aug 14, 2018	SELL	$257.52 - $306.91 $197,260 - $235,093	-766 Reduced 3.33%	22,219 $6.45 Million
Q1 2018 May 15, 2018	BUY	$260.13 - $367.91 $5.69 Million - $8.05 Million	21,883 Added 1985.75%	22,985 $6.29 Million
Q3 2017 Nov 14, 2017	BUY	$281.15 - $329.69 $309,827 - $363,318	1,102	1,102 $345,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

Vanguard Group Inc Valley Forge, PA

16.7M
Shares

$2.44 Billion
0.06% of portfolio
Primecap Management CO Pasadena, CA

16.3M
Shares

$2.39 Billion
2.37% of portfolio
Black Rock Inc. New York, NY

14.5M
Shares

$2.13 Billion
0.08% of portfolio
State Street Corp Boston, MA

7.34M
Shares

$1.08 Billion
0.06% of portfolio
Wellington Management Group LLP Boston, MA

5.13M
Shares

$752 Million
0.18% of portfolio

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account